David Berry's Email & Phone Number

💼 Past Experience

Achievements and Contributions to the Company:Innovator and Entrepreneur. Founder >20 companies. WEF Young Global Leader. David Berry is currently a Board Member at Boston Philharmonic Orchestra from September 2010 to June 2014 (3 years 10 months). Board Member at CGI Pharmaceuticals, Inc. from September 2009 to July 2010 (11 months). Acquired by Gilead in 2010. General Partner at Flagship Pioneering in Cambridge, MA. Creating breakthrough human health and sustainability companies. Founder, CEO (2017-2019), and Board Member at Omega Therapeutics. Controlling insulated genomic domains, the genomstats of the human genome. Founder, CEO (2017-2018), and Board Member at Kintai Therapeutics. Pioneering precision enteric medicines. Founder and Chairman (2017-2018) at Inari. Creating the world's first seed foundry. Founder, Chairman (2013-2015) at Indigo in Cambridge, MA. Harnessing nature to help farmers sustainably feed the planet. Founder at LS9, Inc. from November 2005 to January 2014 (8 years 3 months) in South San Francisco. Acquired by Renewable Energy Group (NASDAQ: REGI) in 2014. Founder, CEO (2010-2014) and Board Member (2010-2015) at Seres Therapeutics in Cambridge, MA. Creating new waves of medicines powered by the microbiomeSeres went public on the Nasdaq in 2015 under the symbol MCRB. Founder, CEO (2009-2012), and Board Member at Axcella Health in Cambridge, MA. Axcella is harnessing the power of Endogenous Metabolic Modulators to transform health and medicineAxcella went public on the NASDAQ under the symbol AXLA in 2019. Founder, CEO (2014-2015), and Board Member (2015-2018) at Evelo Therapeutics in Cambridge, MA. Developing monoclonal microbials: oral biologics that act on the small intestine and act systemicallyEvelo went public on the NASDAQ in 2018 under the symbol EVLO. Founder and Board Member at Eleven Biotherapeutics from September 2009 to August 2016 (7 years) in Cambridge, MA. Eleven Biotherapeutics designs and develops novel biologics for ocular diseases. Eleven went public on the Nasdaq under the symbol EBIO in 2014. Corporation Member at Massachusetts Institute of Technology from June 2006 to June 2011 (5 years 1 month). . Founder and Board Member (2015-2019) at KSQ Therapeutics, Inc. KSQ is a preclinical-stage biotech that has rapidly advanced the field of CRISPR-enabled functional genomics, from in vitro cell autonomous screens to more complex genome-scale screens of immune cells in vivo. Leadership Council Member at United Nations Sustainable Development Solutions Network in Greater New York City Area. The scale of the global sustainable development challenge is unprecedented. The fight against extreme poverty has made great progress under the Millennium Development Goals (MDGs), but more than 1 billion people continue to live in extreme poverty. Inequality and social exclusion are widening within most countries. As the world population is estimated to

🎓 Education

Summary of David Berry's educational background:David Berry's educational background consists of a Doctor of Medicine from Harvard Medical School in 2000, a PhD from Massachusetts Institute of Technology in 2002, and a BS from MIT in 1996. David has spent the past few years working as a Laboratory Scientist in the Biologyengineering department at MIT. While at MIT, he was a part of the team that developed the BRAIN project. This project has been seminal in the development of modern neuroscience, and has helped to elucidate the workings of the brain.

💡 Technical & Interpersonal Skills

David Berry's professional and technical skills include:Innovative and Entrepreneurial Management. Founder >20 companies.WEF Young Global Leader. obtained his B.S. in 2002 from Northeastern University in Boston, MA.He started his career as a technical sales representative for a company that manufactured paper and cardboard products.In 2006, he obtained his M.B.A. from Northeastern University in Boston, MA.He started his career as a technical sales representative for a company that manufactured paper and cardboard products.He has over twenty years of experience in the technical sales industry.He has experience in the management of companies, including sales, marketing, and technical support.He is a Board Member at Boston Philharmonic Orchestra from September 2010 to June 2014 (3 years 10 months).He is a Board Member at CGI Pharmaceuticals, Inc. from September 2009 to July 2010 (11 months).He has experience in the management of companies, including sales, marketing, and technical support.He is a General Partner at Flagship Pioneering in Cambridge, MA.He has experience in the management of companies, including sales, marketing, and technical support.He is a Founding CEO of Omega Therapeutics.He has experience in the management of companies, including sales, marketing, and technical support.He is aCEO of Kintai Therapeutics.He has experience in the management of companies, including sales, marketing, and technical support.He is aPresident and CEO of Inari.He has experience in the management of companies, including sales, marketing, and technical support.He is a Founding Chairman and CEO of Indigo in Cambridge, MA.He has experience in the management of companies, including sales, marketing, and technical support.He is aBoard Member at LS9, Inc. from November 2005 to January 2014 (8 years 3 months) in South San Francisco.He has experience in the management of companies, including sales, marketing, and technical support.He is a Founder, CEO and Board Member at Seres Therapeutics in Cambridge, MA.He has experience in the management of companies, including sales, marketing, and technical support.He is a Founder and CEO of Axcella Health in Cambridge, MA.He has experience in the management of companies, including sales, marketing, and technical support.He is a Founding Chairman and CEO of Evelo Therapeutics in Cambridge, MA.He is aBoardMember at Eleven Biotherapeutics from September 2009 to August 2016 (7 years) in Cambridge, MA.He has experience in the management of companies, including sales, marketing, and technical support.He is aBoard Member of United Nations Sustainable Development Solutions Network in Greater New York City Area.He has experience in management of companies, including sales, marketing, and technical support.He has experience in the management of companies, including sales, marketing, and technical